THIS COMPONENT IS ENTITLED CELL-TO-CELL COMMUNICATIONS IN CANCER PROGRAM ABSTRACT The long-term goal of the new Cell-to-Cell Communications in Cancer Program (C4P) is to unravel the complex cellular communication between tumor and non-tumor cells that is pivotal to cancer development, progression and metastasis. Identifying factors (biochemical and physical), the receptive signaling pathways responsible and the cellular basis for this communication will lay the framework for the design of specific therapeutic modalities. C4P includes individuals focused on understanding how stromal cells and extracellular matrix structural proteins, growth factors and cytokines interact with tumor cells to impact the tumorigenic process. The program is primarily a basic discovery-based cancer biology research group that is structured to interface with other programs within Siteman Cancer Center (SCC) that are positioned to translate breakthroughs into patient care through genetics, molecular and cellular cancer biology, and functional genomics. To facilitate interactions between basic researchers within C4P and clinicians, members are organized around three specific cancer areas: (1) unraveling the molecular mechanisms that impact the metastatic process including how stromal cells impact the premetastatic niche and the immune landscape at the metastatic site; (2) lung cancer development, progression, metastasis and treatment; and (3) brain cancer development, progression and treatment.
The aims of the C4P are to (1) identify key communication molecules and pathways (i.e., targets) in tumor- stromal interactions that impact tumor cell proliferation, survival and metastasis and then to develop strategies to target these key molecules or pathways; and (2) develop select inter-programmatic working groups that can facilitate translational efforts from results that arise from efforts in Aim 1.
Each aim i s focused on the central importance of communication in the cancer microenvironment. Each member has specific expertise and shared goals that have been and will continue to be utilized to develop a program with strong and fruitful intra- programmatic and inter-programmatic interactions. C4P has 39 members from 10 departments and 2 schools and is supported by $16.8 million in funding, of which $3.1 million is from NCI and $12.4 is other peer-reviewed funding. Currently, 28% of C4P members are supported by the NCI and 85% are supported by peer-reviewed funding including agencies such as the ACS, AACR, DOD and Komen. Between 2009-2014, C4P members published 663 peer-reviewed papers with 101 of these publications appearing in journals with impact factors above 10. Members also displayed significant interactions as evidenced by the 150 (23%) inter- and 59 (9%) intra-programmatic publications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA091842-18
Application #
9733933
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
18
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Aliev, Fazil; Salvatore, Jessica E; Agrawal, Arpana et al. (2018) A Brief Critique of the TATES Procedure. Behav Genet 48:155-167
Mills, Jason C; Samuelson, Linda C (2018) Past Questions and Current Understanding About Gastric Cancer. Gastroenterology 155:939-944
Salloum, Naji C; Buchalter, Erica Lf; Chanani, Swati et al. (2018) From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation. Pharmacogenomics 19:861-871
Dehdashti, Farrokh; Wu, Ningying; Bose, Ron et al. (2018) Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer. Breast Cancer Res Treat 169:523-530
Donabedian, Patrick L; Kossatz, Susanne; Engelbach, John A et al. (2018) Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models. EJNMMI Res 8:59
Shepherd, Andrew J; Copits, Bryan A; Mickle, Aaron D et al. (2018) Angiotensin II Triggers Peripheral Macrophage-to-Sensory Neuron Redox Crosstalk to Elicit Pain. J Neurosci 38:7032-7057
Andley, Usha P; Tycksen, Eric; McGlasson-Naumann, Brittney N et al. (2018) Probing the changes in gene expression due to ?-crystallin mutations in mouse models of hereditary human cataract. PLoS One 13:e0190817
Sáenz, José B; Mills, Jason C (2018) Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer. Nat Rev Gastroenterol Hepatol 15:257-273
Groves, Andrew P; Gettinger, Katie; Druley, Todd E et al. (2018) Special Therapy and Psychosocial Needs Identified in a Multidisciplinary Cancer Predisposition Syndrome Clinic. J Pediatr Hematol Oncol :
Ostrander, Elizabeth L; Koh, Won Kyun; Mallaney, Cates et al. (2018) The GNASR201C mutation associated with clonal hematopoiesis supports transplantable hematopoietic stem cell activity. Exp Hematol 57:14-20

Showing the most recent 10 out of 1244 publications